Epstein Secrets

ing on `unsustainable drug prices' concludes — Hybrid hearing on `Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM * Tom Lantos Human

candal before the 2016 election." Graham "asked Comey about the newly declassified information released Tuesday by Director of National Intelligence John Ratcliffe. `You don't remember getting an investigatory lead from the intelligence community? Sept. 7, 2016, U.S. intelligence officials forwarded an investi

ing on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

andal before the 2016 election." Graham "asked Comey about the newly declassified information released Tuesday by Director of National Intelligence John Ratcliffe. 'You don't remember getting an investigatory lead from the intelligence community? Sept. 7, 2016, U.S. intelligence officials forwarded an investig

ring on `unsustainable drug prices' concludes - Hybrid hearing on Unsustainable Drug Prices: Testimony from the CEOs (Part II); with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

andal before the 2016 election." Graham "asked Comey about the newly declassified information released Tuesday by Director of National Intelligence John Ratcliffe. 'You don't remember getting an investigatory lead from the intelligence community? Sept. 7, 2016, U.S. intelligence officials forwarded an investi

ng on 'unsustainable drug prices' concludes - Hybrid hearing on 'Unsustainable Drug Prices: Testimony from the CEOs (Part II)', with testimony from Amgen CEO Robert Bradway; Mallinckrodt Pharmaceuticals CEO Mark Trudeau; and Novartis U.S. Country President Thomas Kendris; 10:00 AM • Tom Lantos Human

andal before the 2016 election." Graham "asked Comey about the newly declassified information released Tuesday by Director of National Intelligence John Ratcliffe. `You don't remember getting an investigatory lead from the intelligence community? Sept. 7, 2016, U.S. intelligence officials forwarded an investi